journal article·2021-08Open access

Influenza Virus Infects and Depletes Activated Adaptive Immune Responders

Caitlin D. Bohannon, Zachary Ende, Weiping Cao, Wadzanai P. Mboko, Priya Ranjan, Amrita Kumar, Margarita Mishina, Samuel Amoah, Shivaprakash Gangappa, Suresh K. Mittal, Jonathan F. Lovell, Adolfo García‐Sastre, Blaine A. Pfeifer, Bruce A. Davidson, Paul Knight, Suryaprakash Sambhara

Advanced Science· Volume 8· Issue 16

Abstract

Abstract Influenza infections cause several million cases of severe respiratory illness, hospitalizations, and hundreds of thousands of deaths globally. Secondary infections are a leading cause of influenza's high morbidity and mortality, and significantly factored into the severity of the 1918, 1968, and 2009 pandemics. Furthermore, there is an increased incidence of other respiratory infections even in vaccinated individuals during influenza season. Putative mechanisms responsible for vaccine failures against influenza as well as other respiratory infections during influenza season are investigated. Peripheral blood mononuclear cells (PBMCs) are used from influenza vaccinated individuals to assess antigen‐specific responses to influenza, measles, and varicella. The observations made in humans to a mouse model to unravel the mechanism is confirmed and extended. Infection with influenza virus suppresses an ongoing adaptive response to vaccination against influenza as well as other respiratory pathogens, i.e., Adenovirus and Streptococcus pneumoniae by preferentially infecting and killing activated lymphocytes which express elevated levels of sialic acid receptors. These findings propose a new mechanism for the high incidence of secondary respiratory infections due to bacteria and other viruses as well as vaccine failures to influenza and other respiratory pathogens even in immune individuals due to influenza viral infections.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Influenza Virus Research Studies · Respiratory viral infections research · Immune Response and Inflammation

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Influenza Division Centers for Disease Control and Prevention Atlanta GA 30329 USA

Oak Ridge Institute for Science and Education (ORISE) CDC Fellowship Program Oak Ridge TN 37831 USA

Department of Comparative Pathobiology and Purdue Institute for Inflammation Immunology and Infectious Disease Purdue University West Lafayette IN 47907 USA

Department of Biomedical Engineering State University of New York at Buffalo Buffalo NY 14260 USA

Global Health and Emerging Pathogens Institute Icahn School of Medicine at Mount Sinai New York NY 10029 USA

Department of Microbiology Icahn School of Medicine at Mount Sinai New York NY 10029 USA

Department of Medicine Division of Infectious Diseases Icahn School of Medicine at Mount Sinai New York NY 10029 USA

The Tisch Cancer Institute Icahn School of Medicine at Mount Sinai New York NY 10029 USA

Department of Chemical and Biological Engineering School of Engineering and Applied Sciences State University of New York at Buffalo Buffalo NY 14260 USA

Department of Anesthesiology Jacobs School of Medicine and Biomedical Sciences State University of New York at Buffalo Buffalo NY 14260 USA

Department of Pathology and Anatomical Sciences School of Medicine and Biomedical Sciences State University of New York at Buffalo Buffalo NY 14260 USA

Research Service Veterans Administration Western New York Healthcare System Buffalo NY 14215 USA

Funding

National Heart, Lung, and Blood Institute · Centers for Disease Control and Prevention · National Institute of Allergy and Infectious Diseases

References (65)

Show source-provided references
1. 10.1016/S0140-6736(17)33293-210.1016/S0140-6736(17)33293-2 ↗
2. 10.1001/jama.2012.19413910.1001/jama.2012.194139 ↗
3. 10.3201/eid2204.15159510.3201/eid2204.151595 ↗
4. 10.1007/s15010-019-01287-510.1007/s15010-019-01287-5 ↗
5. 10.1016/j.apjtm.2017.01.01510.1016/j.apjtm.2017.01.015 ↗
6. 10.1038/s41467-018-07515-010.1038/s41467-018-07515-0 ↗
7. 10.1371/journal.ppat.100756010.1371/journal.ppat.1007560 ↗
8. Mina M. J. · mBio · 2014 · 5
9. 10.1001/archinte.1971.0031018005300610.1001/archinte.1971.00310180053006 ↗
10. 10.1084/jem.114.2.23710.1084/jem.114.2.237 ↗
11. C. Centers for Disease Prevention · Morb. Mortal. Wkly. Rep. · 2009 · 58 · 1071
12. 10.1038/nm.226210.1038/nm.2262 ↗
13. 10.3201/eid1408.07131310.3201/eid1408.071313 ↗
14. 10.1056/NEJMc090821610.1056/NEJMc0908216 ↗
15. 10.3201/eid1502.08120810.3201/eid1502.081208 ↗
16. 10.1038/nm107710.1038/nm1077 ↗
17. 10.1093/infdis/jiv06610.1093/infdis/jiv066 ↗
18. 10.1016/j.vaccine.2008.07.03910.1016/j.vaccine.2008.07.039 ↗
19. 10.3390/v409143810.3390/v4091438 ↗
20. 10.1038/srep4036010.1038/srep40360 ↗
21. 10.1172/JCI11058010.1172/JCI110580 ↗
22. 10.1128/iai.37.2.794-799.198210.1128/iai.37.2.794-799.1982 ↗
23. 10.1128/jvi.50.2.287-292.198410.1128/jvi.50.2.287-292.1984 ↗
24. Gardner I. D. · J. Reticuloendothel. Soc. · 1982 · 32 · 443
25. 10.2217/fmb.09.10810.2217/fmb.09.108 ↗
26. 10.1099/vir.0.2008/004606-010.1099/vir.0.2008/004606-0 ↗
27. Hraiech S. · Drug Des., Dev. Ther. · 2015 · 9 · 3279
28. 10.1128/JVI.00805-0910.1128/JVI.00805-09 ↗
29. 10.1111/j.1462-5822.2010.01475.x10.1111/j.1462-5822.2010.01475.x ↗
30. Warshauer D. · Am. Rev. Respir. Dis. · 1977 · 115 · 269
31. 10.1128/JVI.02455-1410.1128/JVI.02455-14 ↗
32. 10.1016/j.vaccine.2017.06.05810.1016/j.vaccine.2017.06.058 ↗
33. Calimeri S. · Clin. Ter. · 2020 · 171 · 486
34. 10.1186/s12889-016-2987-z10.1186/s12889-016-2987-z ↗
35. 10.5114/ceji.2019.9278910.5114/ceji.2019.92789 ↗
36. 10.1001/archinte.1992.0040019010101910.1001/archinte.1992.00400190101019 ↗
37. 10.1128/JVI.80.7.3675-3678.200610.1128/JVI.80.7.3675-3678.2006 ↗
38. 10.1016/j.micinf.2010.10.00410.1016/j.micinf.2010.10.004 ↗
39. C. Centers for Disease, Prevention · Morb. Mortal. Wkly. Rep. · 2010 · 59 · 1057
40. 10.1128/iai.10.5.996-1002.197410.1128/iai.10.5.996-1002.1974 ↗
41. 10.1371/journal.pone.010092610.1371/journal.pone.0100926 ↗
42. 10.1128/JVI.74.13.6105-6116.200010.1128/JVI.74.13.6105-6116.2000 ↗
43. 10.1084/jem.159.5.132210.1084/jem.159.5.1322 ↗
44. 10.1128/iai.35.3.1142-1146.198210.1128/iai.35.3.1142-1146.1982 ↗
45. 10.1128/iai.25.2.749-756.197910.1128/iai.25.2.749-756.1979 ↗
46. 10.1007/s11604-015-0476-410.1007/s11604-015-0476-4 ↗
47. 10.4049/jimmunol.135.3.213410.4049/jimmunol.135.3.2134 ↗
48. 10.7883/yoken1952.50.2710.7883/yoken1952.50.27 ↗
49. 10.1111/irv.1218210.1111/irv.12182 ↗
50. 10.1016/j.jim.2009.01.00810.1016/j.jim.2009.01.008 ↗
51. 10.1073/pnas.091499410710.1073/pnas.0914994107 ↗
52. 10.1016/j.bbrc.2017.07.01710.1016/j.bbrc.2017.07.017 ↗
53. 10.1016/j.bbrc.2015.07.06110.1016/j.bbrc.2015.07.061 ↗
54. 10.1126/sciimmunol.aay612510.1126/sciimmunol.aay6125 ↗
55. 10.1152/ajplung.00346.201510.1152/ajplung.00346.2015 ↗
56. 10.3892/ijmm.2015.239510.3892/ijmm.2015.2395 ↗
57. 10.1007/s00701-009-0324-310.1007/s00701-009-0324-3 ↗
58. 10.1677/ERC-07-006210.1677/ERC-07-0062 ↗
59. 10.1128/JVI.02293-1610.1128/JVI.02293-16 ↗
60. 10.3389/fmicb.2019.0003910.3389/fmicb.2019.00039 ↗
61. 10.1172/jci.insight.9322210.1172/jci.insight.93222 ↗
62. Cucinotta D. · Acta Biomed. · 2020 · 91 · 157
63. 10.1038/s41565-018-0271-310.1038/s41565-018-0271-3 ↗
64. 10.1002/eji.20083912910.1002/eji.200839129 ↗
65. 10.1097/ALN.000000000000076610.1097/ALN.0000000000000766 ↗